3.23.1 html 137 338 1 false 53 0 false 7 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://vorbiopharma.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 100030 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://vorbiopharma.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 100040 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Sheet http://vorbiopharma.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Statements 4 false false R5.htm 100050 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://vorbiopharma.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) Statements 5 false false R6.htm 100060 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) Sheet http://vorbiopharma.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) Statements 6 false false R7.htm 100070 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://vorbiopharma.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 100080 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) Sheet http://vorbiopharma.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsParenthetical CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) Statements 8 false false R9.htm 100090 - Disclosure - Nature of the Business Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureNatureOfBusiness Nature of the Business Notes 9 false false R10.htm 100100 - Disclosure - Summary of Significant Accounting Policies Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 10 false false R11.htm 100110 - Disclosure - Investments Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureInvestments Investments Notes 11 false false R12.htm 100120 - Disclosure - Fair Value Measurements Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 100130 - Disclosure - Property and Equipment, Net Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNet Property and Equipment, Net Notes 13 false false R14.htm 100140 - Disclosure - Accrued Expenses and Other Current Liabilities Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities Accrued Expenses and Other Current Liabilities Notes 14 false false R15.htm 100150 - Disclosure - Redeemable Convertible Preferred Stock and Stockholders' Equity Sheet http://vorbiopharma.com/20221231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAndStockholdersEquity1 Redeemable Convertible Preferred Stock and Stockholders' Equity Notes 15 false false R16.htm 100170 - Disclosure - Stock-Based Compensation Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensation Stock-Based Compensation Notes 16 false false R17.htm 100180 - Disclosure - Leases Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureLeases Leases Notes 17 false false R18.htm 100190 - Disclosure - Significant Agreements Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureSignificantAgreements Significant Agreements Notes 18 false false R19.htm 100200 - Disclosure - Commitments and Contingencies Sheet http://vorbiopharma.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 19 false false R20.htm 100210 - Disclosure - Defined Contribution Benefit Plan Sheet http://vorbiopharma.com/20221231/taxonomy/role/DisclosureDefinedContributionBenefitPlan Defined Contribution Benefit Plan Notes 20 false false R21.htm 100220 - Disclosure - Income Taxes Sheet http://vorbiopharma.com/20221231/taxonomy/role/DisclosureIncomeTaxes1 Income Taxes Notes 21 false false R22.htm 100230 - Disclosure - Net Loss Per Share Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShare Net Loss Per Share Notes 22 false false R23.htm 100240 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies 23 false false R24.htm 100250 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://vorbiopharma.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies 24 false false R25.htm 100260 - Disclosure - Investments (Tables) Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureInvestmentsTables Investments (Tables) Tables http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureInvestments 25 false false R26.htm 100270 - Disclosure - Fair Value Measurements (Tables) Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurements 26 false false R27.htm 100280 - Disclosure - Property and Equipment, Net (Tables) Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetTables Property and Equipment, Net (Tables) Tables http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNet 27 false false R28.htm 100290 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables Accrued Expenses and Other Current Liabilities (Tables) Tables http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities 28 false false R29.htm 100300 - Disclosure - Stock-Based Compensation (Tables) Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensation 29 false false R30.htm 100310 - Disclosure - Leases (Tables) Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureLeasesTables Leases (Tables) Tables http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureLeases 30 false false R31.htm 100320 - Disclosure - Income Taxes (Tables) Sheet http://vorbiopharma.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables Income Taxes (Tables) Tables http://vorbiopharma.com/20221231/taxonomy/role/DisclosureIncomeTaxes1 31 false false R32.htm 100330 - Disclosure - Net Loss Per Share (Tables) Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareTables Net Loss Per Share (Tables) Tables http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShare 32 false false R33.htm 100340 - Disclosure - Nature of the Business - Additional Information (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails Nature of the Business - Additional Information (Details) Details 33 false false R34.htm 100350 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Summary of Significant Accounting Policies - Additional Information (Details) Details 34 false false R35.htm 100360 - Disclosure - Summary of Significant Accounting Policies - Estimated Useful Life of Property and Equipment (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfPropertyAndEquipmentDetails Summary of Significant Accounting Policies - Estimated Useful Life of Property and Equipment (Details) Details 35 false false R36.htm 100370 - Disclosure - Investments - Summary of Amortized Cost and Estimated Fair Value of Investments by Contractual Maturity (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureInvestmentsSummaryOfAmortizedCostAndEstimatedFairValueOfInvestmentsByContractualMaturityDetails Investments - Summary of Amortized Cost and Estimated Fair Value of Investments by Contractual Maturity (Details) Details 36 false false R37.htm 100380 - Disclosure - Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) Details 37 false false R38.htm 100390 - Disclosure - Fair Value Measurements - Additional Information (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails Fair Value Measurements - Additional Information (Details) Details 38 false false R39.htm 100400 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment, Net (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails Property and Equipment, Net - Schedule of Property and Equipment, Net (Details) Details 39 false false R40.htm 100410 - Disclosure - Property and Equipment, Net - Additional Information (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetails Property and Equipment, Net - Additional Information (Details) Details 40 false false R41.htm 100420 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) Details 41 false false R42.htm 100430 - Disclosure - Redeemable Convertible Preferred Stock and Stockholders' Equity - Additional Information (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAndStockholdersEquityAdditionalInformationDetails Redeemable Convertible Preferred Stock and Stockholders' Equity - Additional Information (Details) Details 42 false false R43.htm 100440 - Disclosure - Stockholders' Equity - Additional Information (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails Stockholders' Equity - Additional Information (Details) Details 43 false false R44.htm 100450 - Disclosure - Stock-Based Compensation - Additional Information (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails Stock-Based Compensation - Additional Information (Details) Details 44 false false R45.htm 100460 - Disclosure - Stock-Based Compensation - Summary of Weighted-Average Assumptions Used Principally in Determining Fair Value of Options Granted (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedPrincipallyInDeterminingFairValueOfOptionsGrantedDetails Stock-Based Compensation - Summary of Weighted-Average Assumptions Used Principally in Determining Fair Value of Options Granted (Details) Details 45 false false R46.htm 100470 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails Stock-Based Compensation - Summary of Stock Option Activity (Details) Details 46 false false R47.htm 100480 - Disclosure - Stock-Based Compensation - Summary of unvested restricted stock units Activity (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfUnvestedRestrictedStockUnitsActivityDetails Stock-Based Compensation - Summary of unvested restricted stock units Activity (Details) Details 47 false false R48.htm 100490 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details) Details 48 false false R49.htm 100500 - Disclosure - Leases - Additional Information (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails Leases - Additional Information (Details) Details 49 false false R50.htm 100510 - Disclosure - Leases - Summary of Lease Expense (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseExpenseDetails Leases - Summary of Lease Expense (Details) Details 50 false false R51.htm 100520 - Disclosure - Leases - Summary of Amounts Reported in Consolidated Balance Sheets and Weight-average Lease Term and Discount rate Information (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfAmountsReportedInConsolidatedBalanceSheetsAndWeightaverageLeaseTermAndDiscountRateInformationDetails Leases - Summary of Amounts Reported in Consolidated Balance Sheets and Weight-average Lease Term and Discount rate Information (Details) Details 51 false false R52.htm 100530 - Disclosure - Leases - Summary of Other Lease Activity (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfOtherLeaseActivityDetails Leases - Summary of Other Lease Activity (Details) Details 52 false false R53.htm 100540 - Disclosure - Leases - Summary of Future Lease Payments for Noncancelable Leases (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails Leases - Summary of Future Lease Payments for Noncancelable Leases (Details) Details 53 false false R54.htm 100550 - Disclosure - Significant Agreements - Additional Information (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails Significant Agreements - Additional Information (Details) Details 54 false false R55.htm 100560 - Disclosure - Defined Contribution Benefit Plan - Additional Information (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/DisclosureDefinedContributionBenefitPlanAdditionalInformationDetails Defined Contribution Benefit Plan - Additional Information (Details) Details 55 false false R56.htm 100570 - Disclosure - Income Taxes - Schedule of Reconciliation of Federal Statutory Income Rate to Effective Income Tax Rate (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeRateToEffectiveIncomeTaxRateDetails Income Taxes - Schedule of Reconciliation of Federal Statutory Income Rate to Effective Income Tax Rate (Details) Details 56 false false R57.htm 100580 - Disclosure - Income Taxes - Schedule of Significant Components of Deferred tax Assets and Liabilities (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails Income Taxes - Schedule of Significant Components of Deferred tax Assets and Liabilities (Details) Details 57 false false R58.htm 100590 - Disclosure - Income Taxes - Additional Information (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails Income Taxes - Additional Information (Details) Details 58 false false R59.htm 100600 - Disclosure - Net Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails Net Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details) Details 59 false false R60.htm 100610 - Disclosure - Net Loss Per Share - Potential Dilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Details) Sheet http://vorbiopharma.com/20221231/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails Net Loss Per Share - Potential Dilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Details) Details 60 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept PropertyPlantAndEquipmentEstimatedUsefulLives in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. vor-20221231.htm 5945 [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate - vor-20221231.htm 8 vor-20221231.htm vor-20221231.xsd vor-20221231_cal.xml vor-20221231_def.xml vor-20221231_lab.xml vor-20221231_pre.xml vor-ex23_1.htm vor-ex31_1.htm vor-ex31_2.htm vor-ex32_1.htm img18312369_0.jpg img18312369_1.jpg img18312369_10.jpg img18312369_11.jpg img18312369_12.jpg img18312369_13.jpg img18312369_14.jpg img18312369_15.jpg img18312369_16.jpg img18312369_17.jpg img18312369_18.jpg img18312369_2.jpg img18312369_3.jpg img18312369_4.jpg img18312369_5.jpg img18312369_6.jpg img18312369_7.jpg img18312369_8.jpg img18312369_9.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true